[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
November 23, 1970

Medical News

JAMA. 1970;214(8):1403-1412. doi:10.1001/jama.1970.03180080009003

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Hepatitis is main subject at blood banks meeting  Just as blood bankers all over the country are feeling intense pressure to use and improve tests for the Australia or Hepatitis Associated Antigen, a New York investigator announced a test which he believes to be 98.6% accurate in screening sera for a so-called "hepatitis factor" that shows no correlation with Au antigen.The pressure, heightened by several announcements at the American Association of Blood Banks meeting in San Francisco, is coming from several sources:

  • † the medical profession's deep concern about the possibility of transmitting a serious illness to patients receiving blood transfusions;

  • † recent court decisions holding blood banks, hospitals, and perhaps physicians liable for damages when a patient develops posttransfusion hepatitis— even if there is no way to prevent such an occurrence and no evidence of negligence;

  • † a growing number of studies showing a correlation between the